Skip to Content

Join the 'Oxymetazoline / tetracaine' group to help and get support from people like you.

Oxymetazoline / tetracaine News

St. Renatus, LLC Announces FDA Approval of Kovanaze (tetracaine HCl and oxymetazoline HCl) Nasal Spray for Use in Dentistry

Posted 1 Aug 2016 by Drugs.com

FORT COLLINS, Colo., July 12, 2016 /PRNewswire/ – St. Renatus, LLC, a privately held company based in Fort Collins, Colorado, is pleased to announce it received U.S. Food and Drug Administration (FDA) approval on June 29, 2016 for its first product, a new dental anesthetic, Kovanaze (tetracaine HCl and oxymetazoline HCl) Nasal Spray. This is the first product that allows for dental anesthesia to be administered through a nasal spray without using a needle. "For more than 100 years, the dental industry has delivered dental anesthesia using a needle injection. Now, through the efforts of a dedicated team, we have developed a revolutionary needle-free method for delivering pulpal anesthesia," said Steve Merrick, St. Renatus' CEO. Kovanaze is intended for use in dentistry as a topical anesthetic, delivered in the nasal cavity to achieve pulpal (tooth nerve) anesthesia for the ... Read more

Related support groups: Local Anesthesia, Kovanaze, Oxymetazoline/tetracaine

Ask a Question

Further Information

Related Condition Support Groups

Local Anesthesia

Related Drug Support Groups

Kovanaze

Oxymetazoline / tetracaine Patient Information at Drugs.com